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Clustering of Poor Device Acceptance and Type D
Personality is Associated with Increased Distress
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Background: Psychosocial risk factors tend to cluster together within individuals, likely enhancing the
risk of adverse health outcomes. We examined (1) the influence of clustering of poor device acceptance
and Type D personality on anxiety and depressive symptoms, and (2) the demographic and clinical
determinants of patients with clustering, in a large cohort of Danish implantable cardioverter defibrillator
(ICD) patients.
Methods: Patients (N = 557; 81.9% male; mean age = 61.9 ± 14.3 years) implanted with an ICD
between 1989 and 2006 were asked to complete a set of standardized and validated questionnaires and
were divided into four risk groups: (1) No risk factors (neither poor device acceptance nor Type D), (2)
Poor device acceptance only, (3) Type D only, (4) Clustering (both poor device acceptance and Type D).
Results: The prevalence of anxiety was significantly higher in patients with clustering of risk factors
(54.2%) compared to patients with poor device acceptance (30.0%), Type D personality (26.5%), or no risk
factors (7.6%) (χ2 = 88.472; df = 3; P < 0.001). Similarly, the prevalence of depression was higher in the
clustering group (47.2%) compared to patients with poor device acceptance (19.1%), Type D personality
(23.5%), or no risk factors (1.8%) (Fisher’s exact = 112.874; df = 3; P < 0.001). Patients with the clustering
of poor device acceptance and Type D had the highest mean scores of anxiety (P < 0.001) and depression
(<0.001), also when adjusting for demographic and clinical baseline characteristics including shocks.
Shocks (P = 0.006) were associated with increased anxiety but not with depression (P = 0.31).
Conclusion: Patients with poor device acceptance and Type D personality should be identified and
monitored in clinical practice, as they may benefit from adjunctive intervention in order to experience the
same quality of life benefits following implantation as other patients. Given the cross-sectional nature of
the study, these findings should be confirmed using a prospective study design. (PACE 2009; 32:29–36)
anxiety, clustering, defibrillator acceptance, depressive symptoms, implantable cardioverter
defibrillator, Type D personality
Introduction
Psychosocial risk factors tend to cluster to-
gether within individuals, likely enhancing the
risk of adverse health outcomes, including in-
creased distress and poor quality of life in patients
subject to clustering.1 However, in patients with
cardiovascular disease (CVD), the tendency has
been to examine the impact of single psychoso-
cial risk factors,1 although focusing on the im-
pact of clustering may lead to more accurate risk
This research was in part supported with a VENI grant (451-
05-001) to Dr. Susanne S. Pedersen from the Netherlands Orga-
nization for Scientific Research, The Hague, The Netherlands.
Address for reprints: Susanne S. Pedersen, Ph.D., CoRPS, De-
partment of Medical Psychology, Room P506, Tilburg Univer-
sity, Warandelaan 2, P.O. Box 90153, 5000 LE Tilburg, The
Netherlands. Fax: +31 13 466 2067; e-mail: s.s.pedersen@uvt.nl
Received June 2, 2008; revised July 16, 2008; accepted Septem-
ber 23, 2008.
estimation in individual patients. Recent Dutch
studies of patients treated with percutaneous coro-
nary intervention with drug-eluting stents and pa-
tients with an implantable cardioverter defibrilla-
tor (ICD) support this notion.2,3 In the latter study,
the clustering of Type D personality and ICD con-
cerns was shown to incur an increased risk of anxi-
ety 6 months postimplantation compared with the
presence of one (i.e., Type D or ICD concerns) or
no risk factors, whereas the impact of clustering
was less clear for depression.
Type D personality is a potential risk fac-
tor in CVD that has been associated both with
patient-centered outcomes, such as poor quality
of life, but also with adverse clinical events, in-
cluding mortality and morbidity.4–8 Type D per-
sonality has also been shown to be of value in
arrhythmia research.9,10 Type D is defined as the
tendency to experience increased negative emo-
tions paired with emotional nonexpression.4,5 Pa-
tients with this personality disposition typically
C©2009, The Authors. Journal compilation C©2009, Blackwell Publishing, Inc.
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worry, feel down in the dumps, and get easily ir-
ritated, while bottling up these negative emotions
due to fear of rejection and negative reactions from
others.4,11
Personality factors in general and Type D per-
sonality in particular may interact with device ac-
ceptance to increase the risk of anxiety and de-
pression in ICD patients. Device acceptance can
be conceptualized as the psychological accommo-
dation of the device in the patient’s life, including
a positive view towards the ICD as a life-saving
necessity.12,13 Previously, device acceptance has
been associated with less anxiety, depression, and
illness intrusiveness, and better quality of life,
but the study did not examine the influence of
clustering of poor device acceptance and other
psychosocial factors on outcomes.12 In a recent
study of the present sample, we also found that
Type D personality was a correlate of poor device
acceptance.14
Hence, in the current study, we examined (1)
the influence of clustering of poor device accep-
tance and Type D personality on anxiety and de-
pressive symptoms, and (2) the demographic and
clinical determinants of patients with clustering,
in a large cohort of surviving ICD patients im-
planted at a single center in Denmark.
Methods
Patients and Study Design
Patients implanted with an ICD at Aarhus Uni-
versity Hospital (Skejby), Denmark, since 1989
and still alive on November 1, 2006, comprised
the study population. Patients with a first ICD im-
plant within the last 3 months were excluded. The
majority of patients (94.8%) had a secondary in-
dication for ICD, since prophylactic implantation
was not generally implemented in Denmark prior
to 2007. More details of the study design have been
published previously.15 Of 723 eligible patients,
624 (86%) participated.15 For the current study,
analyses were based on 557 patients (81.9% male;
mean age = 61.9 ± 14.3 years; mean time since ICD
implantation = 4.9 ± 3.2 years) who had complete
data on the psychological questionnaires used in
the current study.
All surviving patients were informed about
the study by mail and asked to complete a self-
report questionnaire containing questions on clin-
ical data and standardized and validated psycho-
logical questionnaires. If patients did not return
the questionnaire within 2 weeks, they were sent
a reminder including a duplicate of the question-
naire. The study was conducted to conform to the
Helsinki Declaration.
Measures
Demographic and Clinical Variables
Information on demographic (i.e., sex, age,
having a partner, education, and working status)
and clinical variables (i.e., CVD etiology, cardiac
resynchronization therapy, comorbidity, device-
related complications, and shocks) and medi-
cation (i.e., amiodarone, β-blockers, angiotensin
converting enzyme (ACE)-inhibitors, diuretics,
thiazide, and psychotropics) were obtained from
purpose-designed questions in the questionnaire,
the patients’ medical records, and the Danish ICD
registry.16 The 21-item Minnesota Living With
Heart Failure (MLHF) questionnaire, a disease-
specific quality of life measure, was used to derive
a proxy for symptomatic heart failure,17 as infor-
mation on New York Heart Association (NYHA)
functional status was not standardly registered in
the Danish ICD registry at the time when it was
set up. The MLHF is a valid and reliable mea-
sure, with items scored on a 6-point Likert scale
from 0 (no) to 5 (very much). The score range is
0–105 for the total scale, with a lower score rep-
resenting good quality of life. The MLHF score
was dichotomized in order to enhance the clin-
ical interpretability,18 using a cut-off >40 (the
75% upper percentile in our data) to represent
NYHA class III–IV (i.e., symptomatic congestive
heart failure).19
Acceptance of the Cardioverter-Defibrillator
The 18-item Florida Patient Acceptance Sur-
vey (FPAS) is a disease-specific measure assess-
ing device acceptance.13 Items are rated on a 5-
point Likert scale from 0 (strongly disagree) to 5
(strongly agree), with a high score indicating more
acceptance. Of all items, 15 contribute to four sub-
scales: (1) Return to Function (four items; e.g., I am
confident about my ability to work if I want to); (2)
Device-Related Distress (five items; e.g., When I
think about the device, I avoid doing things that
I enjoy); (3) Positive Appraisal (four items; e.g.,
I would receive this device again); and (4) Body
Image Concerns (two items; e.g., I feel less attrac-
tive because of my device). The remaining three
items are filler items. A total score based on the
15 items may also be calculated.13 The conver-
gent, divergent, and discriminant validity of the
FPAS are good, and the scale has been shown
to be internally consistent, as indicated by Cron-
bach’s α ranging from 0.74 to 0.83.13 The valid-
ity and reliability of the Danish version of the
FPAS was recently confirmed in the present co-
hort of ICD patients, with device acceptance as as-
sessed by the total score on the FPAS correlating
inversely with anxiety (r = –0.53) and depressive
symptoms (r = –0.57).14 These correlations, with
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a shared variance of only 28–32%, indicate that
device acceptance is conceptually different from
measures of anxiety and depressive symptoms,
despite some overlap. In the current study, we
only used the total FPAS score.
Type D Personality
The 14-item Type D Scale (DS14) was used
to assess Type D personality, which is a normal
personality taxonomy developed in cardiac pa-
tients.4,11 The DS14 consists of two 7-item sub-
scales, that is, negative affectivity (e.g., I often
feel unhappy) and social inhibition (e.g., I am
a closed kind of person).11 Items are answered
on a five-point Likert scale ranging from 0 (false)
to 4 (true), with a score range from 0 to 28 for
both subscales. A standardized cut-off ≥10 on
both subscales is used to categorize patients as
having a Type D personality,11 with this cut-
off being the most optimal as confirmed by item
response theory.20 It is the combination of the
two personality traits (i.e., negative affectivity
and social inhibition) rather than the single traits
that incurs an increased risk of adverse clini-
cal events.6 Type D is not confounded by dis-
ease severity,21,22 and has in patients with acute
myocardial infarction been shown to be stable
during an 18-month period.21 The psychometric
properties of the scale are good, with Cronbach’s
α of 0.88/0.86 and 3-month test–retest reliability
r = 0.72/0.82 for the negative affectivity and social
inhibition subscales, respectively.11
Anxiety and Depressive Symptoms
The 14-item Hospital Anxiety and Depression
Scale (HADS) C© was used to assess symptoms of
anxiety and depression.23 The HADS is comprised
of two subscales (i.e., a seven-item anxiety and
a seven-item depression subscale). Items are an-
swered on a four-point Likert scale from 0 to 3,
with a score range from 0 to 21 for each subscale.
A cut-off score ≥8 has been shown to provide
the most optimal balance between sensitivity and
specificity.24 Hence, we used this cut-off in the
current study to indicate probable clinical levels
of anxiety and depression. The HADS is a valid
and reliable instrument that has been used across
the world in cardiac and noncardiac populations,
including in outpatients.24,25 An advantage of the
HADS is that it is devoid of somatic symptoms,
decreasing the likelihood that probable clinical
levels of anxiety and depression are inflated in
somatic patients.25
Statistical Analyses
Prior to statistical analyses, patient scores on
the FPAS were dichotomized using the lowest ter-
tile to indicate poor device acceptance. FPAS was
dichotomized in order to be consistent with a pre-
vious study of the current sample that used the
same cut-off on the FPAS.14 Subsequently, we cre-
ated four risk groups, based on device acceptance
and Type D personality, as follows: (1) No risk
factors (neither poor device acceptance nor Type
D; n = 341; 61.2%), (2) Poor device acceptance
only (n = 110; 19.7%), (3) Type D only (n = 34;
6.1%), and (4) Clustering (both poor acceptance
and Type D; n = 72; 12.9%). The percentage of pa-
tients in each group does not add up to 100% due
to rounding. The χ2 test (Fisher’s exact test when
appropriate) was used to examine differences be-
tween the four risk groups on nominal baseline
characteristics and analysis of variance (ANOVA),
with a post hoc Bonferroni correction, on continu-
ous characteristics. ANOVA with a post hoc Bon-
ferroni correction was also used to compare the
four risk groups on mean scores of anxiety and
depression. To rule out the potentially confound-
ing effects of demographic and clinical character-
istics on the influence of the four risk groups on
anxiety and depression, respectively, analysis of
covariance (ANCOVA) was used, adjusting for all
baseline characteristics, as presented in Table I.
In a subsequent analysis, using logistic regres-
sion analysis, we examined whether patients sub-
ject to risk factor clustering differed from the other
three groups (i.e., those with one or no risk fac-
tors) on demographic and clinical characteristics.
Hence, prior to these analyses, the three groups
with one or no risk factors were merged into one
and used as reference category for the clustering
group. Given that the sample size in the clustering
group was 72 and in order to avoid overfitting of
the regression model, we first conducted a series of
univariable logistic regression analyses, and chose
to include in the multivariable model only those
characteristics listed in Table I that were signifi-
cant at <0.05. All tests were two-tailed. A P-value
<0.05 was used to indicate statistical significance.
All analyses were performed using SPSS 14.0 for
Windows (SPSS Inc., Chicago, IL, USA).
Results
Study Participants Versus Nonparticipants
on Baseline Characteristics
Patients (n = 557) included in the analyses
did not differ systematically from nonparticipants
and those with incomplete psychological data for
the current study (n = 166) on gender, age, coro-
nary artery disease (CAD) etiology, cardiac resyn-
chronization therapy defibrillator (CRT-D), and
device-related complications (results not shown).
However, patients included in the analyses were
more likely to have had their ICD for fewer
years compared to nonparticipants and those with
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Table I.
Baseline Patient Characteristics Stratified by Risk Groups*
None Poor Device Acceptance Type D Clustering
(n = 341) (n = 110) (n = 34) (n = 72) P
Demographics
Female gender 18.5 (63) 16.4 (18) 20.6 (7) 18.1 (13) 0.94
Agea 60.3 (14.9)# 64.0 (12.3) 60.5 (16.3) 66.6 (11.8)# 0.002
Partner/living together 79.8 (272) 69.1 (76) 82.4 (28) 73.6 (53) 0.06
Educationb 27.0 (92) 15.5 (17) 14.7 (5) 13.9 (10) 0.01
Working 34.6 (118) 15.5 (17) 17.6 (6) 4.2 (3) <0.001
Clinical
Nonischemic etiology 41.1 (140) 37.3 (41) 35.3 (12) 31.9 (23) 0.49
Symptomatic heart failurec 10.9 (37) 47.3 (52) 17.6 (6) 56.9 (41) <0.001
CRT-D 17.0 (58) 22.7 (25) 8.8 (3) 23.6 (17) 0.16
Comorbidityd 19.6 (67) 26.4 (29) 17.6 (6) 27.8 (20) 0.22
Device-related complications 8.5 (29) 9.1 (10) 2.9 (1) 8.3 (6) 0.78
Shocks 42.8 (146) 41.8 (46) 32.4 (11) 47.2 (34) 0.50
Years since implantationa 4.8 (3.2) 4.3 (3.3) 4.5 (3.2) 4.9 (3.1) 0.46
Medication
Amiodarone 19.4 (66) 28.2 (31) 14.7 (5) 40.3 (29) 0.001
β-blockers 81.2 (277) 81.1 (90) 73.5 (25) 76.4 (55) 0.90
ACE-inhibitors 65.7 (224) 77.3 (85) 58.8 (20) 59.7 (43) 0.08
Diuretics 39.9 (136) 54.5 (60) 32.4 (11) 56.9 (41) 0.004
Thiazide 9.4 (32) 10.0 (11) 11.8 (4) 6.9 (5) 0.83
Psychotropic medication 9.7 (33) 14.5 (16) 11.8 (4) 27.8 (20) 0.001
*Presented as% (n) unless otherwise indicated.
#Post hoc Bonferroni correction was significant between the two groups (P = 0.004).
aPresented as mean (±SD).
b>9 years.
cBased on the 75th percentile on the Minnesota Living with Heart Failure Questionnaire,17 which was MLHF > 40 in the current study.
dFor example, cancer.
CRT-D = cardiac resynchronization therapy with an ICD.
incomplete data (4.68 ± 3.24 vs 5.49 ± 3.62;
P = 0.006).
Baseline Characteristics
Baseline characteristics stratified by the four
risk groups, based on device acceptance and
Type D personality, are shown in Table I. The risk
groups differed significantly on age (P = 0.002), ed-
ucation (P = 0.01), working status (P < 0.001), the
presence of symptomatic heart failure (P < 0.001),
the use of amiodarone (P = 0.001), diuretics (P =
0.004), and psychotropic medication (P = 0.001),
with patients with the clustering of poor device
acceptance and Type D personality being older;
having lower education; less likely to be work-
ing; and more likely to have symptomatic heart
failure, to take amiodarone, diuretics, and psy-
chotropic medication compared to the other three
groups.
Prevalence of Anxiety and Depression, Stratified
by Device Acceptance and Personality
The overall prevalence of probable clinical
levels of anxiety and depression, as defined by a
cut-off of ≥8 on the HADS,24 was 19.2% (95% CI:
16.2%–22.7%) and 12.4% (95% CI: 9.9%–15.4%),
respectively. The prevalence rates for probable
anxiety and depression with their corresponding
95% confidence intervals, stratified by device ac-
ceptance and Type D personality, are presented
in Figure 1. The prevalence of anxiety was signifi-
cantly higher in patients with clustering of risk fac-
tors (54.2%; 95% CI: 42.7%–65.2%) compared to
patients with poor device acceptance only (30.0%;
95% CI: 22.2%–39.1%), Type D personality only
(26.5%; 95% CI: 14.6%–43.1%), or no risk factors
(7.6%; 95% CI: 5.3%–10.9%) (χ2 = 88.472; df = 3;
P < 0.001). Similarly, the prevalence of depression
was higher in the clustering group (47.2%; 95% CI:
36.1% – 58.6%) compared to patients with poor
32 January 2009 PACE, Vol. 32


































































Figure 1. Prevalence rates for probable anxiety and de-
pression (the prevalence of symptoms of anxiety and
depression was determined with the standardized cut-
off ≥ 8 on the Hospital Anxiety and Depression Scale
[24], indicating probable clinical levels but not a clinical
diagnosis of anxiety and depression) with their corre-
sponding 95% confidence intervals, stratified by device
acceptance and Type D personality.
device acceptance only (19.1%; 95% CI: 12.8%–
27.4%), Type D personality only (23.5%; 95% CI:
12.4%–40.0%), or no risk factors (1.8%; 95% CI:
0.8%–3.8%) (Fisher’s exact = 112.874; df = 3;
P < 0.001).
Mean Anxiety and Depression Scores, Stratified
by Device Acceptance and Personality
(unadjusted)
Dichotomization of outcome measures has
been advocated in order to enhance the clinical
interpretability and applicability of the results,18
but from a statistical point of view dichotomiza-
tion may lead to the loss of information. Hence,
in order to confirm the differential associations
found for the four risk groups in relation to the
prevalence of anxiety and depression, we also
performed ANOVAs using continuous scores on
the HADS.
The results found in relation to the prevalence
rates were confirmed using continuous scores,
with levels of anxiety being highest in patients
with clustering of poor device acceptance and
Type D (mean = 8.40 ± 4.25), with scores in pa-
tients with poor device acceptance only (mean =
5.91 ± 3.86) and Type D only (mean = 5.10 ± 3.80)
being almost equal, followed by the no-risk factor
group (mean = 2.71 ± 2.99) who had the lowest
scores (F (3,553) = 69.780; P < 0.001). The find-
ings were similar for depression, with levels of de-
pression being highest in patients with clustering
of poor device acceptance and Type D (mean =
7.25 ± 3.52), with scores in patients with poor
device acceptance only (mean = 4.96 ± 3.11)
and Type D only (mean = 5.41 ± 3.48) being al-
most equal, followed by the no-risk factor group
(mean = 1.70 ± 1.88) who had the lowest scores
(F(3,553) = 127.625; P < 0.001). For both anx-
iety and depression, all post hoc comparisons
were statistically significant except for mean dif-
ferences between the poor device acceptance only
and Type D only groups.
Mean Anxiety and Depression Scores, Stratified
by Device Acceptance and Personality (Adjusted)
To rule out that the influence of cluster-
ing of device acceptance and Type D personal-
ity on anxiety and depression could be attributed
to confounders, we ran ANCOVAs adjusting for
gender, age, having a partner, education, work-
ing status, CAD etiology, symptomatic heart fail-
ure, CRT-D, comorbidity, device-related compli-
cations, shocks, years since implantation, and
medication (i.e., amiodarone, β-blockers, ACE-
inhibitors, diuretics, thiazide, and psychotropics).
In adjusted analysis, the influence of clus-
tering of device acceptance and Type D person-
ality on anxiety was still statistically significant
(F (3,437) = 36.242; P < 0.001). Female gender
(F (1,437) = 10.102; P = 0.002), symptomatic heart
failure (F (1,437) = 11.483; P = 0.001), shocks
(F (1,437) = 7.679; P = 0.006), and the use of psy-
chotropic medication (F (1,437) = 6.225; P = 0.01)
were also independently associated with anxiety,
whereas none of the other covariates were signifi-
cant (all Ps > 0.05). The model accounted for 34%
(adjusted R2) of the variance in anxiety.
Similarly, the influence of clustering of de-
vice acceptance and Type D personality on depres-
sive symptoms was still statistically significant (F
(3,437) = 50.772; P < 0.001) in adjusted analysis.
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Other independent associates were symptomatic
heart failure (F (1,437) = 27.246; P < 0.001) and the
use of psychotropic medication (F (1,437) = 8.533;
P = 0.004). Shocks were not a significant correlate
of depression (F (1,437) = 1.022; P = 0.31) nor
were any of the other covariates (all Ps > 0.05).
The model accounted for 42% (adjusted R2) of the
variance in depression.
Determinants of Clustering of Poor Device
Acceptance and Type D Personality
Given that patients with clustering of poor de-
vice and Type D personality were more likely to be
anxious and depressed compared to patients with
one or no risk factors, we examined whether pa-
tients subject to risk factor clustering differed from
the other three groups on demographic and clini-
cal characteristics. Knowledge of the demographic
and clinical determinants of clustering is impor-
tant in order to be able to identify these high-risk
patients in clinical practice.
All baseline characteristics listed in Table I
were entered as potential determinants of cluster-
ing in separate logistic regression analyses. Only
age; working status; symptomatic heart failure;
and the use of amiodarone, diuretics, and psy-
chotropic medication were statistically significant
determinants of clustering (all Ps < 0.05; results
not shown). Subsequently, these variables were
entered together in a multivariable logistic regres-
sion analysis. Patients with clustering of poor de-
vice acceptance and Type D personality were less
likely to be working (OR: 0.14; 95% CI: 0.03–0.67),
and more likely to have symptomatic heart fail-
ure (OR: 4.15; 95% CI: 2.26–7.62) and use psy-
chotropic medication (OR: 2.18; 95% CI: 1.14–
4.17) compared to patients with one or no risk
Table II.
Determinants of Clustering of Poor Device Acceptance
and Type D Personality*
OR [95% CI] P
Age 1.00 [0.97–1.03] 0.73
Working 0.14 [0.03–0.67] 0.01
Symptomatic heart failurea 4.15 [2.26–7.62] <0.001
Amiodarone 1.86 [1.00–3.46] 0.05
Diuretics 0.78 [0.42–1.46] 0.44
Psychotropic medication 2.18 [1.14–4.17] 0.02
*Logistic regression analysis (multivariable), using a merging of
one or no risk factors as the reference category.
aBased on the 75th percentile on the Minnesota Living with
Heart Failure Questionnaire,17 which was MLHF > 40 in the
current study.
factors (Table II). Although the use of amiodarone
was not statistically significant, there was a clear
trend for patients with clustering being more likely
to be prescribed amiodarone (OR: 1.86; 95% CI:
1.00–3.46).
Discussion
A paucity of studies have examined the im-
pact of clustering of psychosocial risk factors on
patient-centered outcomes in CVD in general and
patients treated with ICD therapy in particular, de-
spite that a focus on clustering may lead to a more
accurate risk estimation in individual patients. In
the current study of a large cohort of surviving ICD
patients implanted at a single center in Denmark,
we focused on the clustering of two psychoso-
cial factors (i.e., device acceptance and Type D
personality) that have separately been associated
with psychological distress and poor quality of
life in ICD patients. Previously, device acceptance
has been linked to decreased anxiety and depres-
sion and better quality of life,12 whereas Type D
has been shown to increase psychological distress
and predict poor quality of life.9,10 Recently, we
also found that Type D personality was a corre-
late of poor device acceptance, as measured by the
FPAS.14
In the current study, the clustering of poor de-
vice acceptance and Type D personality was asso-
ciated with the highest levels of anxiety and de-
pression compared to groups with one or none
of these risk factors. These results remained un-
changed, adjusting for baseline and clinical char-
acteristics including shocks. These findings are
consistent with the results of recent Dutch studies
of percutaneous coronary intervention patients2
and ICD patients.3 In the latter study, the cluster-
ing of Type D personality and ICD concerns (i.e.,
concerns about the ICD giving a shock) was asso-
ciated with the highest levels of anxiety compared
to the presence of one or no risk factors, although
the influence of clustering was less clear for de-
pression.3
The findings of our study also support the no-
tion that the ICD is generally well tolerated by the
majority of patients, with clinical levels of anx-
iety and depression only occurring in a subset
of patients, and with the prevalence rates in our
study (12–19%) being well below those reported
(25–33%) in reviews of psychosocial adaptation
to ICD therapy.26,27 These differences in preva-
lence rates may in part be attributed to the cross-
sectional design of our study and patients being
implanted with their ICD a mean of 4.9 years ago,
with the likelihood that anxiety and depression
levels may have decreased in our cohort of patients
compared to, e.g., the first 6–12 months follow-
ing implantation. Generally, patients experience
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improvements in quality of life and a decrease in
distress in the first year following implantation,
likely due to adaptation to living with an ICD.3,10,26
Although shocks were a statistically significant as-
sociate of anxiety in the current study, shocks were
not related to depressive symptoms. Similarly, in
a previous study of the current sample focusing
on device acceptance as the outcome, shocks were
not significantly related to acceptance of the ICD,
with device acceptance being better predicted by
the psychological profile of the patient and the
presence of symptomatic heart failure,14 which
has also been found by others.12 This begs the
question whether we should start looking beyond
shocks to also examine the role of a wide range of
psychological factors, as previously posited.14
In clinical practice, it is worthwhile to iden-
tify patients at risk of psychosocial risk factor
clustering due to their increased levels of psycho-
logical distress and adverse health outcomes, as
shown in this cohort of Danish patients and other
studies of Dutch patients.2,3 In the current sam-
ple, patients who were not working, had symp-
tomatic heart failure, and who were prescribed
amiodarone and used psychotropic medication
were more likely to be at risk for clustering. Hence,
health care providers should be particularly alert
when seeing patients with this profile in clinical
practice, as they are at risk for clustering of psy-
chosocial risk factors and increased psychological
distress. In addition to looking at their clinical and
socio-demographic profile, the FPAS and Type D
Scale could be administered as screening tools in
clinical practice. If patients are confirmed both to
have poor device acceptance and a Type D per-
sonality, they should be offered adjunctive inter-
vention either to prevent the onset of anxiety and
depression, or to reduce levels of distress, if al-
ready manifest, in order to improve their quality of
life.28,29 Such intervention should target the psy-
chological profile of patients, incorporating a cog-
nitive behavioral component, but also education
about the ICD; what to expect from the ICD, in-
cluding shocks; and how to cope with the unique
features of the ICD (e.g., teaching patients to have
a shock plan), as this may serve to lessen the im-
pact of shocks on patient-centered outcomes.29 In
combination with cardiac rehabilitation, this may
be the best approach for countering the manifesta-
tion of psychological distress.30 Focusing on these
high-risk patients, which form 19.7% in the cur-
rent study, may also be more cost-effective from
the point of view of offering adjunctive interven-
tion to those patients who need it the most.
The results of the current study should be in-
terpreted with some caution, as patients included
in the analyses differed from nonparticipants and
those with incomplete psychological data on num-
ber of years since implantation, with those in-
cluded in the analyses having had their ICD for
a shorter period of time. In addition, the third risk
group (i.e., Type D only) was based on a relatively
small number of patients (n = 34), and the study
design was cross-sectional, which makes it impos-
sible to draw causal inferences. Moreover, we had
no information on disease severity, such as left
ventricular ejection fraction (LVEF), changes in
medication, and worsening of heart failure, which
might have influenced outcome, as this informa-
tion was not listed standardly in the Danish ICD
registry.16 However, previous studies found no
influence of LVEF on patient-centered outcomes,
such as anxiety, depression, and quality of life.3,10
Information on some of the clinical variables was
also based on self-report, which may be subject to
bias. In addition, the majority of the sample (i.e.,
94.8%) was comprised of secondary prevention
patients, with the results not necessarily general-
izing to primary prevention patients, even though
there is no evidence to date to indicate that in-
dication for ICD may impact on patient-centered
outcomes.10,31,32 Finally, all psychological mea-
sures were self-report rather than interview-based.
Nevertheless, all questionnaires were standard-
ized and validated and included both generic and
disease-specific measures.
In conclusion, patients with clustering of poor
device acceptance and Type D personality re-
ported the highest levels of anxiety and depres-
sion compared to groups with one or none of these
risk factors. These results remained unchanged,
adjusting for baseline and clinical characteristics
including shocks. Patients who were subject to
clustering were more likely to have symptomatic
heart failure, not to be working, and to be pre-
scribed amiodarone and psychotropic medication.
Although these findings should be confirmed us-
ing a prospective study design, it may be timely to
shift from studying the influence of single risk fac-
tors on patient-centered outcomes, even though
analyses may adjust for other psychosocial risk
factors, as focusing on clustering may provide a
more realistic picture of the risk to patients. If
the findings of the current study are confirmed in
future research, patients with a Type D person-
ality and poor acceptance of their device should
be identified and monitored in clinical practice,
as they may benefit from adjunctive intervention
that includes a psychosocial component in or-
der to reduce symptoms of anxiety and depres-
sion, such that they experience the same qual-
ity of life benefits following implantation as other
patients. An advantage of using the FPAS com-
pared to measures of anxiety and depression in
future studies in ICD patients is that the FPAS
is applicable to all patients, whereas measures
of anxiety and depression are only relevant to a
subgroup.
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